Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.